Marine Aussedat, Jennifer Jean-Louis, Orchidee Djahangirian and Marie-Sophie Brochet Pages 208 - 215 ( 8 )
Background: Clomiphene is normally used in women with ovulatory dysfunction. In men, it is used off label in some cases of infertility. Psychological adverse effects are reported in women but very few in men.
Case: A 34-year-old man treated with clomiphene for oligoteratospermia presented anxiety, decreased appetite, and mood change making him unable to function properly at work, five days after initiation of therapy. Symptoms required reduction followed by discontinuation of treatment four days later because of absence of improvement. Following cessation, the patient noted a gradual then a complete resolution approximately one week later. The patient did not have any psychiatric or other medical condition neither drug nor substance abuse that could explain this clinical presentation. The Naranjo's score was used to prove the clomiphene's imputability.
Conclusion: Health care providers should advise patients of the risk of psychological adverse effects when initiating treatment with clomiphene and should provide a close monitoring of mood change, especially during the initial weeks.
Anxiety, clomiphene, drug-related side effects and adverse reactions, infertility, male, mood disorders.
Pharmacy Department, Unite de Recherche en Pratique Pharmaceutique, Sainte-Justine University Hospital Center, Montreal, Quebec, Pharmacy Department, Unite de Recherche en Pratique Pharmaceutique, Sainte-Justine University Hospital Center, Montreal, Quebec, Department of Urology, Male Infertility, Sainte-Justine University Hospital Center, Montreal, Quebec, CHU Sainte-Justine, 3175 Chemin de la Cote-Sainte-Catherine, Montreal (Quebec) H3T 1C5